Global marketsUpdated 3h ago

WSJ sees possible shareholder upside in CVS pharmacy split

The Wall Street Journal says CVS’s planned pharmacy spin-off could leave shareholders with a more valuable company. Its analysis also says the move won’t quiet the company’s critics in Washington: a possible financial upside doesn’t mean the political criticism goes away.

1 publisher1 report

Coverage started 3h ago